Milligan Michael Lee

Insider profile

Milligan Michael Lee's trades of Neumora Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-19 2026-02-17 PlS Planned sale
68,290 +2.1%
235.25
US$4,569,221
68,290 +2.1% 235.25 US$4,569,221
2026-02-17 2026-02-17 PrS Proposed sale
77,380
183.48
US$794,511
77,380 183.48 US$794,511
2025-02-20 2025-02-18 PlS Planned sale
95,025 +10.2%
234.11
US$2,714,856
95,025 +10.2% 234.11 US$2,714,856
2025-02-18 2025-02-18 PrS Proposed sale
1,978
1.69
US$3,351
1,978 1.69 US$3,351